- Kopel J, Perisetti A, Gajendran M, Boregowda U, Goyal H. Clinical insights into the gastrointestinal manifestations of COVID-19. Dig Dis Sci. 2020;65(7):1932–1939. doi:https://doi.org/10.1007/s10620-020-06362-8.
- Bindi E, Cruccetti A, Ilari M, et al. Meckel’s diverticulum perforation in a newborn positive to Sars-Cov-2. J Pediatr Surg Case Rep. 2020;62:101641. doi:https://doi.org/10.1016/j.epsc.2020.101641.
- Giuffrè M, Bozzato AM, Di Bella S, et al. Spontaneous rectal perforation in a patient with SARS–CoV-2 infection. JPM. 2020;10(4):157. doi:https://doi.org/10.3390/jpm10040157.
- Kangas-Dick A, Prien C, Rojas K, et al. Gastrointestinal perforation in a critically ill patient with COVID-19 pneumonia. SAGE Open Med Case Rep. 2020;8:2050313X20940570. doi:https://doi.org/10.1177/2050313X20940570.
- Karam C, Badiani S, Berney CR. COVID-19 collateral damage: delayed presentation of a perforated rectal cancer presenting as Fournier's gangrene. ANZ J Surg. 2020;90(7-8):1483–1485. doi:https://doi.org/10.1111/ans.16104.
- Rohit G, Hariprasad CP, Kumar A, Kishor S, Kumar D, Paswan SS. Effective management of a firearm injury with multiple intestinal perforation in a COVID 19 positive patient: a rare case report. Int J Surg Case Rep. 2020;77:5–8. doi:https://doi.org/10.1016/j.ijscr.2020.10.077.
- Rojo M, Cano-Valderrama O, Picazo S, et al. Gastrointestinal perforation after treatment with tocilizumab: an unexpected consequence of COVID-19 pandemic. Am Surg. 2020;86(6):565–566. doi:https://doi.org/10.1177/0003134820926481.
- Vikse J, Henry BM. Tocilizumab in COVID-19: beware the risk of intestinal perforation. Int J Antimicrob Agents. 2020;56(1):106009. doi:https://doi.org/10.1016/j.ijantimicag.2020.106009.
- Gonzálvez Guardiola P, Díez Ares JÁ, Peris Tomás N, Sebastián Tomás JC, Navarro Martínez S. Intestinal perforation in patient with COVID-19 infection treated with tocilizumab and corticosteroids. Report of a clinical case. Cir Esp. 2020;S0009-739X(20)30167-6. doi:https://doi.org/10.1016/j.ciresp.2020.04.030.
- Plummer MP, Blaser AR, Deane AM. Stress ulceration: prevalence, pathology and association with adverse outcomes. Crit Care. 2014;18(2):213. doi:https://doi.org/10.1186/cc13780.
- Pan Y, Zhang D, Yang P, Poon LLM, Wang Q. Viral load of SARS-CoV-2 in clinical samples. Lancet Infect Dis. 2020;20(4):411–412. doi:https://doi.org/10.1016/S1473-3099(20)30113-4.
- Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631–637. doi:https://doi.org/10.1002/path.1570.
- Tian Y, Rong L, Nian W, He Y. Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission. Aliment Pharmacol Ther. 2020;51(9):843–851. doi:https://doi.org/10.1111/apt.15731.
- Wang J, Li Q, Yin Y, et al. Excessive neutrophils and neutrophil extracellular traps in COVID-19. Front Immunol. 2020;11:2063. doi:https://doi.org/10.3389/fimmu.2020.02063.
- Laforge M, Elbim C, Frère C, et al. Tissue damage from neutrophil-induced oxidative stress in COVID-19. Nat Rev Immunol. 2020;20(9):515–516. doi:https://doi.org/10.1038/s41577-020-0407-1.
- Middleton EA, He X-Y, Denorme F, et al. Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood. 2020;136(10):1169–1179. doi:https://doi.org/10.1182/blood.2020007008.
- Kong M, Zhang H, Cao X, Mao X, Lu Z. Higher level of neutrophil-to-lymphocyte is associated with severe COVID-19. Epidemiol Infect. 2020;148:e139–e139. doi:https://doi.org/10.1017/S0950268820001557.
- Barnes BJ, Adrover JM, Baxter-Stoltzfus A, et al. Targeting potential drivers of COVID-19: neutrophil extracellular traps. J Exp Med. 2020;217(6):e20200652. doi:https://doi.org/10.1084/jem.20200652.
- Mönkemüller K, Fry L, Rickes S. COVID-19, coronavirus, SARS-CoV-2 and the small bowel. Rev Esp Enferm Dig. 2020;112(5):383–388. doi:https://doi.org/10.17235/reed.2020.7137/2020.
- Wu C, Zheng M, Yang Y, et al. Furin: a potential therapeutic target for COVID-19. iScience. 2020;23(10):101642. doi:https://doi.org/10.1016/j.isci.2020.101642.
Free access
Traumatic jejunal perforation associated with SARS-CoV-2 (COVID-19) infection
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.